ACCELERON PHARMA INC's ticker is XLRN and the CUSIP is 00434H108. A total of 1 filers reported holding ACCELERON PHARMA INC in Q4 2021. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2021 | $608,718 | +32.8% | 3,537 | -3.2% | 0.01% | +50.0% |
Q2 2021 | $458,415 | -5.4% | 3,653 | +2.2% | 0.01% | -14.3% |
Q1 2021 | $484,535 | +1.6% | 3,573 | -4.2% | 0.01% | 0.0% |
Q4 2020 | $477,088 | +11.5% | 3,729 | -1.9% | 0.01% | 0.0% |
Q3 2020 | $427,839 | +28.9% | 3,802 | +9.1% | 0.01% | +16.7% |
Q2 2020 | $332,016 | -72.5% | 3,485 | -74.1% | 0.01% | -76.9% |
Q1 2020 | $1,207,673 | +63.1% | 13,438 | -3.8% | 0.03% | +116.7% |
Q4 2019 | $740,477 | +31.2% | 13,966 | -2.3% | 0.01% | +20.0% |
Q3 2019 | $564,598 | -1.6% | 14,290 | +2.3% | 0.01% | 0.0% |
Q2 2019 | $573,600 | -11.8% | 13,963 | 0.0% | 0.01% | -16.7% |
Q1 2019 | $650,257 | +20.4% | 13,963 | +12.6% | 0.01% | +9.1% |
Q4 2018 | $540,020 | -22.9% | 12,400 | +1.4% | 0.01% | -15.4% |
Q3 2018 | $700,152 | -99.9% | 12,234 | 0.0% | 0.01% | +30.0% |
Q2 2018 | $593,594,000 | +24.1% | 12,234 | 0.0% | 0.01% | +42.9% |
Q1 2018 | $478,349,000 | +94063.2% | 12,234 | +2.2% | 0.01% | 0.0% |
Q4 2017 | $508,000 | -69.2% | 11,968 | -72.9% | 0.01% | -30.0% |
Q3 2017 | $1,648,000 | +145.6% | 44,164 | +100.0% | 0.01% | +100.0% |
Q2 2017 | $671,000 | +25.4% | 22,082 | +9.2% | 0.01% | +25.0% |
Q1 2017 | $535,000 | +3.7% | 20,217 | 0.0% | 0.00% | 0.0% |
Q4 2016 | $516,000 | -29.5% | 20,217 | 0.0% | 0.00% | -20.0% |
Q3 2016 | $732,000 | +6.6% | 20,217 | 0.0% | 0.01% | 0.0% |
Q2 2016 | $687,000 | +41.6% | 20,217 | +10.1% | 0.01% | +25.0% |
Q1 2016 | $485,000 | -36.0% | 18,367 | +18.1% | 0.00% | -33.3% |
Q4 2015 | $758,000 | +95.9% | 15,546 | 0.0% | 0.01% | +100.0% |
Q3 2015 | $387,000 | -22.8% | 15,546 | -1.9% | 0.00% | -25.0% |
Q2 2015 | $501,000 | +1.4% | 15,844 | +22.0% | 0.00% | 0.0% |
Q1 2015 | $494,000 | -2.4% | 12,985 | 0.0% | 0.00% | 0.0% |
Q4 2014 | $506,000 | +28.8% | 12,985 | 0.0% | 0.00% | +33.3% |
Q3 2014 | $393,000 | -10.9% | 12,985 | 0.0% | 0.00% | 0.0% |
Q2 2014 | $441,000 | +137.1% | 12,985 | +141.3% | 0.00% | +200.0% |
Q1 2014 | $186,000 | -44.3% | 5,382 | -36.2% | 0.00% | -50.0% |
Q4 2013 | $334,000 | – | 8,439 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
GREAT POINT PARTNERS LLC | 917,767 | $52,524,000 | 8.19% |
Foresite Capital Management II, LLC | 220,268 | $12,606,000 | 4.66% |
Foresite Capital Management III, LLC | 250,863 | $14,357,000 | 3.17% |
Novo Holdings A/S | 650,000 | $37,200,000 | 2.95% |
QVT Financial LP | 190,977 | $10,930,000 | 2.82% |
Perceptive Advisors | 1,528,205 | $87,459,000 | 2.34% |
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 1,117,651 | $63,963,000 | 2.29% |
Asymmetry Capital Management, L.P. | 39,912 | $2,284,000 | 2.11% |
SECTORAL ASSET MANAGEMENT INC | 298,726 | $17,096,000 | 1.82% |
Stanley-Laman Group, Ltd. | 125,020 | $7,155,000 | 1.76% |